Prostatype Genomics AB (publ) (PROGEN.ST)

SEK 10.3

(-8.04%)

Total Assets Summary of Prostatype Genomics AB (publ)

Prostatype Genomics AB (publ)'s latest annual total assets in 2023 was 49.22 Million SEK , up 59.04% from previous year.
Prostatype Genomics AB (publ)'s latest quarterly total assets in 2024 Q1 was 32.27 Million SEK , down -34.44% from previous quarter.
Prostatype Genomics AB (publ) reported annual total assets of 30.95 Million SEK in 2022, down -23.01% from previous year.
Prostatype Genomics AB (publ) reported annual total assets of 40.2 Million SEK in 2021, up 19.43% from previous year.
Prostatype Genomics AB (publ) reported quarterly total assets of 32.27 Million SEK for 2024 Q2, down 0.0% from previous quarter.
Prostatype Genomics AB (publ) reported quarterly total assets of 49.22 Million SEK for 2023 Q4, down 0.0% from previous quarter.

Annual Total Assets Chart of Prostatype Genomics AB (publ) (2023 - 2015)

Historical Annual Total Assets of Prostatype Genomics AB (publ) (2023 - 2015)

Year	Total Assets	Total Assets Growth
2023	49.22 Million SEK	59.04%
2022	30.95 Million SEK	-23.01%
2021	40.2 Million SEK	19.43%
2020	33.66 Million SEK	0.0%
2018	17.57 Million SEK	-10.84%
2017	19.71 Million SEK	-0.01%
2016	19.71 Million SEK	375.57%
2015	4.14 Million SEK	0.0%

Year	Total Assets	Total Assets Growth
2024 Q1	32.27 Million SEK	-34.44%
2024 Q2	32.27 Million SEK	0.0%
2023 Q4	49.22 Million SEK	0.0%
2023 FY	49.22 Million SEK	59.04%
2023 Q3	49.22 Million SEK	41.6%
2023 Q2	34.76 Million SEK	46.52%
2023 Q1	23.72 Million SEK	-23.35%
2022 Q4	30.95 Million SEK	-21.46%
2022 Q3	39.4 Million SEK	38.22%
2022 FY	30.95 Million SEK	-23.01%
2022 Q2	28.51 Million SEK	-16.54%
2022 Q1	34.16 Million SEK	-15.03%
2021 FY	40.2 Million SEK	19.43%
2021 Q2	26.46 Million SEK	-7.68%
2021 Q1	28.67 Million SEK	-14.83%
2021 Q4	40.2 Million SEK	-11.6%
2021 Q3	45.48 Million SEK	71.84%
2020 Q3	21.57 Million SEK	-12.3%
2020 Q2	24.59 Million SEK	0.0%
2020 FY	33.66 Million SEK	0.0%
2020 Q4	33.66 Million SEK	56.06%
2019 Q3	15.59 Million SEK	0.0%
2018 FY	17.57 Million SEK	-10.84%
2017 FY	19.71 Million SEK	-0.01%
2016 FY	19.71 Million SEK	375.57%
2015 FY	4.14 Million SEK	0.0%

Peer Total Assets Comparison of Prostatype Genomics AB (publ)

Name	Total Assets	Total Assets Difference
AroCell AB (publ)	174.89 Million SEK	71.856%
Devyser Diagnostics AB (publ)	510.1 Million SEK	90.351%
Immunovia AB (publ)	98.68 Million SEK	50.12%
SenzaGen AB	97.17 Million SEK	49.348%
Spermosens AB	26.1 Million SEK	-88.554%